Expenditure on medicines is a readily identifiable element of health service costs. As such, it is the focus of much attention by payers, not least in the UK despite the fact that the ex-manufacturer cost of medicines represents less than 10% of total UK National Health Service (NHS)...

Expenditure on medicines is a readily identifiable element of health service costs. As such, it is the focus of much attention by payers, not least in the UK despite the fact that the ex-manufacturer cost of medicines represents less than 10% of total UK National Health Service (NHS)...

The objective of this briefing is to summarise concisely the evidence on incentives that encourage providers of health care to follow guidance on best practice, particularly where that guidance requires the use of specific medicines or other health technologies. We define incentives broadly, to...

There has been long-standing interest in the use of incentives to encourage delivery of high-quality health care services at the lowest feasible cost. Although it is clear that health care professionals have intrinsic incentives to deliver high-quality care to patients, there are significant...